Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2014
12/30/2014US8921366 Substituted triazolo-pyridazine derivatives
12/30/2014US8921365 Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
12/30/2014US8921363 Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors
12/30/2014US8921362 6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors
12/30/2014US8921361 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
12/30/2014US8921359 Inhibitors of beta-secretase
12/30/2014US8921358 Apoptosis signal-regulating kinase 1 inhibitors
12/30/2014US8921357 Pyridazinone derivatives
12/30/2014US8921356 Compositions comprising nicotinic agonists and methods of using same
12/30/2014US8921355 Macrocyclic indole derivatives useful as hepatitis C virus inhibitors
12/30/2014US8921354 Heterocyclic compound
12/30/2014US8921353 Heteroaryl pyridone and aza-pyridone compounds
12/30/2014US8921352 Pharmaceutical composition comprising simvastatin and ezetimibe
12/30/2014US8921351 Liquid crystalline phytosterol-glycerine complex for enhanced bioavailability and water dispersal
12/30/2014US8921350 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
12/30/2014US8921349 Compounds and methods for treating AIDS and HIV infections
12/30/2014US8921348 Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists
12/30/2014US8921347 Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system
12/30/2014US8921346 Preparation method of drospirenone
12/30/2014US8921345 Pharmaceutical composition for emergency contraception
12/30/2014US8921344 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
12/30/2014US8921343 Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
12/30/2014US8921342 Liver function-protecting agent
12/30/2014US8921341 Antiviral compounds
12/30/2014US8921340 Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
12/30/2014US8921338 Fluid compositions for improving skin conditions
12/30/2014US8921337 Carboxyvinyl polymer-containing nanoparticle suspensions
12/30/2014US8921336 Small molecule myristate inhibitors of BCR-ABL and methods of use
12/30/2014US8921333 Therapeutic agent for tumor
12/30/2014US8921332 Chromosomal modification involving the induction of double-stranded DNA cleavage and homologous recombination at the cleavage site
12/30/2014US8921330 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
12/30/2014US8921328 E-selectin antagonists
12/30/2014US8921327 Ectoparasiticidal methods and formulations
12/30/2014US8921326 Sustained-release composition and method for producing the same
12/30/2014US8921321 Therapeutic strategies for prevention and treatment of alzheimer's disease
12/30/2014US8921320 Targeted osmotic lysis of cancer cells
12/30/2014US8921316 Stable liquid VEGF antagonist formulations
12/30/2014US8921312 Combination of insulin and ascorbate to enhance wound healing
12/30/2014US8921311 Method for treating hyperglycemia
12/30/2014US8921303 Extended release fragrance compositions
12/30/2014US8921106 Antibodies that bind the glutamate ligand binding region of NOTCH3
12/30/2014US8921100 Use of the adenoviral E2 late promoter
12/30/2014US8921069 Eukaryotic microorganisms for producing lipids and antioxidants
12/30/2014US8920864 Sensation masking composition
12/30/2014US8920855 Methods of topically treating tinnitus and related disorders
12/30/2014US8920854 Oral care compositions for treating xerostomia
12/30/2014US8920845 Method of producing microcapsules
12/30/2014US8920844 Methods for enhancing the release and absorption of water insoluble active agents
12/30/2014US8920843 Slow release of organic salts of local anesthetics for pain relief
12/30/2014US8920841 Biodegradable polymer system
12/30/2014US8920840 Enteric tablet
12/30/2014US8920839 Dry-coated orally-disintegrating tablet
12/30/2014US8920838 Delayed-release glucocorticoid treatment of rheumatoid disease
12/30/2014US8920837 Sustained release dosage form
12/30/2014US8920835 Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof
12/30/2014US8920834 Misuse preventative, controlled release formulation
12/30/2014US8920833 Misuse preventative, controlled release formulation
12/30/2014US8920832 Composition for nucleic acid transfection
12/30/2014US8920831 Lidocaine-containing hydrogel patch
12/30/2014US8920824 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
12/30/2014US8920823 Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
12/30/2014US8920822 Skin beautifier
12/30/2014US8920821 Pharmaceutical compositions comprising silica microspheres
12/30/2014US8920820 Highly concentrated stable meloxicam solutions for needleless injection
12/30/2014US8920814 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
12/30/2014US8920809 Chimera comprising bacterial cytotoxin and methods of using the same
12/30/2014US8920797 Highly concentrated stabilized IgM solution
12/30/2014US8920793 Biodegradable PAOX polymer particle with cationic property
12/30/2014US8920789 Use of polymer D-lactic acid (PDLA) or equivalents thereof to inhibit growth of cancer cells and diagnose cancers
12/30/2014US8920788 High-molecular weight conjugate of physiologically active substances
12/30/2014US8920786 Shampoo composition having improved care properties
12/30/2014US8920782 Topical bioadhesive formulations
12/30/2014US8920781 Carrier particles for use in dry powder inhalers
12/30/2014US8920774 Drug having regulatory cell ligand contained in liposome
12/30/2014US8920392 Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
12/30/2014CA2806526C Trans-clomiphen for type 2 diabetes
12/30/2014CA2791166C Pyrazolopyrimidine compounds and their use as pde10 inhibitors
12/30/2014CA2776692C Penetrating pharmaceutical foam
12/30/2014CA2730793C Azole compound
12/30/2014CA2670690C Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid
12/30/2014CA2666762C Aminomethyl-4-imidazoles
12/30/2014CA2666653C Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide
12/30/2014CA2655159C Glycine transporter-1 inhibitors
12/30/2014CA2655014C Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/30/2014CA2652008C A process for the preparation of a taxane derivative
12/30/2014CA2649194C Pharmaceutical composition that comprises an analgesic and vitamins
12/30/2014CA2645833C Compositions containing riboflavin and sesamin-class compounds
12/30/2014CA2627541C Oxazole compound and pharmaceutical composition
12/30/2014CA2626865C Macromolecular compounds having controlled stoichiometry
12/30/2014CA2618479C Pyrazine derivatives and use as pi3k inhibitors
12/30/2014CA2612324C N-acyl derivatives of amino acids, a process for preparation thereof, a pharmaceutical composition and use thereof as antiallergic, anti-inflammatory and hypolipidemic agents
12/30/2014CA2611935C Synergistic prebiotic compositions
12/30/2014CA2594433C Compositions comprising the 2s,4r ketoconazole enantiomer for treating diabetes, metabolic syndrome and other conditions
12/30/2014CA2583092C Antiangiogenic calixarene-based peptide mimetics
12/30/2014CA2403533C Methods and systems for enhancing fluid flow through an obstructed vascular site
12/25/2014US20140378944 Methods for drug delivery
12/25/2014US20140378917 Transdermal therapeutic system with a low tendency to spontaneously crystallize
12/25/2014US20140378888 (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders
12/25/2014US20140378673 Prodrug using nitroimidazole
12/25/2014US20140378668 Tyrosine Bioconjugation through Aqueous Ene-Like Reactions
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 7860